Atria Wealth Solutions, Inc. Eyenovia, Inc. Transaction History

Atria Wealth Solutions, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.99 - $2.37 $4,950 - $11,850	5,000 Added 17.86%	33,000 $32,000
Q2 2023 Aug 03, 2023	SELL	$2.21 - $5.75 $6,630 - $17,250	-3,000 Reduced 9.68%	28,000 $66,000
Q1 2023 Jun 14, 2023	BUY	$1.72 - $3.53 $5,160 - $10,590	3,000 Added 10.71%	31,000 $109,000
Q1 2023 May 10, 2023	SELL	$1.72 - $3.53 $5,160 - $10,590	-3,000 Reduced 9.68%	28,000 $98,000
Q4 2022 Aug 30, 2023	BUY	$1.54 - $2.74 $4,620 - $8,220	3,000 Added 10.71%	31,000 $50,000
Q4 2022 Feb 13, 2023	SELL	$1.54 - $2.74 $4,620 - $8,220	-3,000 Reduced 8.82%	31,000 $50,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $2.48 $52,700 - $84,320	34,000 New	34,000 $66,000

13.4M

13.1K

21.3K

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $2.74M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.